Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | PARP3 | Q9Y6F1 | 1/20 | 0.32 |
| ▸ | CTSC | P53634 | 2/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | FCER2 | P06734 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31527602 | 0.91 | QRFPR (0.36) | SLC15A2 | |
| SCHEMBL23544661 | 0.90 | SLC15A2 (0.34) | SLC15A2CTSC | |
| SCHEMBL22133100 | 0.90 | QRFPR (0.35) | — | |
| SCHEMBL2319309 | 0.89 | PARP1 (0.38) | PARP1PARP3MMP1FCER2 | |
| SCHEMBL1666820 | 0.89 | SLC15A2 (0.42) | SLC15A2CTSC | |
| SCHEMBL483799 | 0.89 | SLC15A2 (0.42) | SLC15A2CTSC | |
| Hydrochloric Acid SCHEMBL1436163 | 0.87 | SLC15A2 (0.41) | SLC15A2CTSC | |
| Hydrochloric Acid SCHEMBL2199717 | 0.87 | SLC15A2 (0.41) | SLC15A2CTSC | |
| SCHEMBL4588249 | 0.87 | SLC15A2 (0.41) | SLC15A2CTSC | |
| SCHEMBL30954680 | 0.87 | SLC15A2 (0.41) | SLC15A2CTSC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025005781-A1 | ANTIMICROBIAL PEPTOID COMPRISING N-TERMINAL METAL COMPLEX | 광주과학기술원 | 2025-01-02 | — | — | WO | claimed |
| EP-4630029-A1 | METHODS AND COMPOSITIONS FOR TREATING OCULAR LESIONS | ONL Therapeutics, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| EP-4630031-A2 | METHODS AND COMPOSITIONS FOR IMPROVING VISUAL FUNCTION IN OCULAR DISEASES AND DISORDERS | ONL Therapeutics, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| WO-2025005781-A1 | ANTIMICROBIAL PEPTOID COMPRISING N-TERMINAL METAL COMPLEX | 광주과학기술원 | 2025-01-02 | — | — | WO | disclosed |
| WO-2024124030-A2 | METHODS AND COMPOSITIONS FOR IMPROVING VISUAL FUNCTION IN OCULAR DISEASES AND DISORDERS | ONL THERAPEUTICS, INC. (US) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024124035-A1 | METHODS AND COMPOSITIONS FOR TREATING OCULAR LESIONS | ONL THERAPEUTICS, INC. (US) | 2024-06-13 | — | — | WO | disclosed |